REGN
Regeneron Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +8.3% ·
aandelenstroom +4.1% ·
netto nieuwe posities +7.7%
· formule
Brede accumulatie: stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | -1 | 74.11K | $47.57M | n/a | −4 |
| Q2 2026 | 167 | -1 | 75.04M | $46.86B | +5 | −7 |
| Q1 2026 | 172 | -4 | 77.87M | $60.04B | +2 | −7 |
| Q4 2025 | 175 | 0 | 81.03M | $62.54B | +1 | n/a |
| Q3 2025 | 27 | -1 | 48.96M | $27.52B | n/a | −2 |
| Q2 2025 | 26 | +2 | 40.24M | $21.12B | +3 | −1 |
| Q1 2025 | 21 | +1 | 16.62M | $10.53B | +1 | n/a |
| Q4 2024 | 20 | -1 | 17.24M | $12.28B | n/a | −1 |
| Q3 2024 | 20 | +1 | 13.10M | $13.76B | +2 | −1 |
| Q2 2024 | 19 | n/a | 13.77M | $14.47B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 9.42M | n/a | $4.95B | 0.1% | n/c | 1 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (passief) | 9.28M | n/a | $4.87B | 0.1% | n/c | 1 | SEC ↗ ×22 |
| 3 | State Street Global Advisors ✦ (passief) | 4.83M | +0.9% | $2.54B | 0.1% | ▲ Add | 3 | SEC ↗ |
| 4 | Dodge & Cox ✦ | 3.83M | +64.6% | $2.01B | 1.1% | ▲ Add | 5 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 3.33M | n/a | $1.75B | 0.1% | n/c | 1 | SEC ↗ ×5 |
| 6 | Geode Capital Management ✦ (passief) | 2.47M | -0.2% | $1.29B | 0.1% | ▼ Trim | 5 | SEC ↗ ×2 |
| 7 | Capital World Investors ✦ | 1.97M | +1.4% | $1.03B | 0.1% | ▲ Add | 5 | SEC ↗ |
| 8 | Norges Bank ✦ (passief) | 1.20M | +6.0% | $628.15M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 777.47K | +34.3% | $408.17M | 0.4% | ▲ Add | 5 | SEC ↗ ×2 |
| 10 | T. Rowe Price ✦ | 766.44K | -64.8% | $402.38M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 11 | Citadel Advisors ✦ | 680.50K | +808.5% | $357.27M | 0.3% | ▲ Add | 5 | SEC ↗ ×2 |
| 12 | Two Sigma Investments ✦ | 499.83K | +34.3% | $262.41M | 0.5% | ▲ Add | 4 | SEC ↗ |
| 13 | Millennium Management ✦ | 338.83K | +99.8% | $177.88M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 14 | Marshall Wace ✦ | 239.91K | +17036.4% | $125.95M | 0.2% | ▲ Add | 5 | SEC ↗ ×3 |
| 15 | Point72 Asset Management ✦ | 143.11K | Nieuw | $75.13M | 0.2% | New | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 114.74K | -51.4% | $59.68M | 0.0% | ▼ Trim | 5 | SEC ↗ ×6 |
| 17 | Adage Capital Partners ✦ | 95.63K | +3.1% | $50.21M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 18 | Bridgewater Associates ✦ | 89.05K | +324.2% | $46.75M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 19 | Wellington Management ✦ | 71.16K | +308.6% | $37.36M | 0.0% | ▲ Add | 5 | SEC ↗ ×7 |
| 20 | Renaissance Technologies ✦ | 45.06K | -42.9% | $23.66M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 27.00K | -15.7% | $14.18M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 22 | Scion Asset Management ✦ | 15.00K | Nieuw | $7.88M | 14.0% | New | 1 | SEC ↗ |
| 23 | ARK Investment Management ✦ | 12.61K | -8.0% | $6.62M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 24 | Arrowstreet Capital ✦ | 6.06K | Nieuw | $3.18M | 0.0% | New | 1 | SEC ↗ |
| 25 | Fisher Asset Management ✦ | 4.35K | 0.0% | $2.29M | 0.0% | Held | 5 | SEC ↗ |
| 26 | GAMCO Investors ✦ | 602 | +2.2% | $316,050 | 0.0% | ▲ Add | 5 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Point72 Asset Management | $75.13M | 0.2% |
| Scion Asset Management | $7.88M | 14.0% |
| Arrowstreet Capital | $3.18M | 0.0% |
Verlaten
| Viking Global Investors | $61.99M | was 0.2% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1,385 houders, 83.52M aandelen, $61.43B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 50 aand · $39,074
Officer · 127 aand · $97,701
Officer · 12 aand · $9,242
Officer · 283 aand · $218,351
Officer · 211 aand · $163,010
Officer · 224 aand · $173,242
Officer · 121 aand · $93,712
Officer · 376 aand · $291,573
Officer · 66 aand · $51,236
Officer · 38 aand · $29,555
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie